Global BioTherapeutics USA Inc., a biotechnology company focused on gene therapies for severe genetic disorders and chronic disease, has filed patent applications for the gene therapy platform and related technologies. GBT is currently developing proprietary technologies for the delivery of genes for the treatment of orphan diseases of inborn errors of metabolism and type I diabetes. GBT's IP is represented by patent counsel from Dentons, LLP.